← All Evoke Pharma INC filings

Evoke Pharma INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

EVOK
Evoke Pharma INC
SCHEDULE: Evoke Pharma Acquired, Nantahala Divests Holdings
Nantahala Capital Management and its principals have ceased beneficial ownership of Evoke Pharma Inc following its acquisition at $11.00 per share.
EVOK
Evoke Pharma INC
SCHEDULE: Investor Acquires 10.5% Stake in Evoke Pharma Amidst Merger
Roger M. Klein and the Krieger Charitable Trust acquired a 10.5% stake in Evoke Pharma Inc. following the announcement of a tender offer by QOL Medical, LLC at $11.00 per share.
EVOK
Evoke Pharma INC
SCHEDULE: Nantahala Capital Backs Evoke Pharma's $11/Share Merger
Nantahala Capital Management and its principals have affirmed their support for Evoke Pharma's acquisition by QOL Medical at $11.00 per share.
EVOK
Evoke Pharma INC
SCHEDULE 13D/A: Nantahala Capital Engages Evoke Pharma on Second Board Designee, Maintains 15.99% Stake
Nantahala Capital Management, along with its principals, has initiated discussions with Evoke Pharma, Inc. regarding the appointment of a second board designee, while maintaining a beneficial ownership of 15.99% of the company's common stock.